Apyx Medical Corp (APYX) — 10-Q Filings
All 10-Q filings from Apyx Medical Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Apyx Narrows Losses, Boosts Q3 Sales Amid AYON Launch
— Nov 6, 2025 Risk: high
Apyx Medical Corp (APYX) reported a net loss of $1.955 million for the three months ended September 30, 2025, a significant improvement from the $4.724 million -
Apyx Medical Q2 Loss Widens Slightly Amidst Stable Per-Share Metrics
— Aug 7, 2025 Risk: medium
Apyx Medical Corp reported a net loss of $1.05 million for the second quarter of 2025, a slight increase from the $1.00 million net loss in the second quarter o -
Apyx Medical Corp. Q1 2025 10-Q Filing
— May 8, 2025 Risk: low
Apyx Medical Corp. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $37.8 million and total liabilities of $0.001 milli -
Apyx Medical Corp. Q3 2024: Assets Surge to $75M
— Nov 8, 2024 Risk: medium
Apyx Medical Corp. reported its Q3 2024 results, with total assets reaching $75 million as of September 30, 2024, compared to $34.6 million at the end of 2023. -
Apyx Medical Corp Files Q2 2024 10-Q
— Aug 8, 2024 Risk: medium
Apyx Medical Corp filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The company, formerly known as Bovie Medical Corp, -
Apyx Medical Corp Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: low
Apyx Medical Corp (APYX) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Apyx Medical Corp filed its 10-Q report for the period ending March 31, 20
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX